Advertisement

Topics

Netherlands Genomics Initiative NGI Company Profile

22:48 EDT 20th June 2018 | BioPortfolio

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further strengthening of the knowledge base (research, technology and education).

Location

P.O. Box 93035
The Hague
2509 AA
Netherlands

Contact

Phone: 31 70 344 0672, +31 70 344 0640
Fax: 31 70 344 0632
Email: info@genomics.nl


News Articles [737 Associated News Articles listed on BioPortfolio]

New initiative launched to support goals of Human Cell Atlas

Uri Laserson, PhD, Assistant Professor in the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai, and collaborators have been awarded one of 85 grants announce...

Berry Genomics Collaborates with 10X Genomics for Next-Gen Prenatal Tests

Berry Genomics of Beijing will collaborate with California's 10X Genomics to develop next-gen noninvasive prenatal tests (NIPT). Specifically, the companies will incorporate 10X's haplotype genomic in...

Genomics England announces appointment of global genomics pioneer as first CEO

Genomics England announces the appointment of its first Chief Executive Officer (CEO) today. Global genomics pioneer Professor John Mattick will join Genomics England in June. He will lead the organiz...

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency

A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle me...

UCSF Names First Chief Genomics Officer

David RathsRecognizing that genomics is playing an increasingly important role in medicine, the University of California San Francisco Health has appointed its first chief genomics officer (CGO).

HL7 Meeting to Focus on Intersection of Clinical Genomics, AI

David RathsGrant Wood, a member of the HL7 Clinical Genomics Work Group and a senior strategist at Intermountain Healthcare’s Clinical Genetics Institute, talks about the confluence of genomics and ...

UC Santa Cruz Cancer Research Awarded Precision Medicine Grant

Heather LandiThe California Initiative to Advance Precision Medicine (CIAPM) has awarded a state grant to the Treehouse Childhood Cancer Initiative of the UC Santa Cruz Genomics Institute for continue...

Clinical Trials [474 Associated Clinical Trials listed on BioPortfolio]

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response to IVF Drugs

The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs, prior to proceeding to oocyte donation ...

Resuscitation Outcomes in the Netherlands

The Resuscitation Outcomes in the Netherlands - study assesses one-year survival and quality of life after In-Hospital Cardiac Arrest(IHCA). It's design is a multicenter prospective observ...

Ethical Dilemmas in Anaesthesiology in the Netherlands; a Qualitative Interview Study.

This study will describe which ethical dilemmas are experienced by anesthesiologist in the Dutch Healthcare system and what the current solving strategies are for these issues. Semi- struc...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Quality Initiative in Rectal Cancer (QIRC) Trial

The Quality initiative in rectal cancer (QIRC) trial will test if a strategy designed to positively influence surgeon practice can decrease hospital rates of permanent colostomy and local ...

Companies [865 Associated Companies listed on BioPortfolio]

Netherlands Genomics Initiative NGI

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further stre...

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughpu...

Dyadic Nederland BV

Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, the Netherlands that is dedicated to research and development activities for the benefit of Dyadic, ...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Netherlands Genomics Initiative NGI" on BioPortfolio

We have published hundreds of Netherlands Genomics Initiative NGI news stories on BioPortfolio along with dozens of Netherlands Genomics Initiative NGI Clinical Trials and PubMed Articles about Netherlands Genomics Initiative NGI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Netherlands Genomics Initiative NGI Companies in our database. You can also find out about relevant Netherlands Genomics Initiative NGI Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record